June 24, 2026 · Form 4 insider transaction
Cohen Ann bought 31,746 shares of Niagen Bioscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Option vests 100% on June 24, 2027.